VENTAK AV AICD VENTAK PRIZM DR/VR, VITALITY, COFIENT, AND TELIGEN AUTOMATIC IMPLANTABLE CARDIOVETER DEFIBRILLATOR SYSTEM
Boston Scientific · Decision date Sep 16, 2025
What did the FDA decide?
FDA records P960040/S509 as a supplement to PMA P960040, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Sep 16, 2025.
FDA approval order statement
addition of alternate supplier Xylem Co for feedthrough pin components
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 16, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P960040/S509
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- LWS
- Decision code
- OK30
- Decision date
- Sep 16, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Boston Scientific
- Product code
- LWS
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P960040/S509 received
Application receipt date recorded by FDA.
P960040/S509 · FDA decision
30-Day Notice
P960040/S508 · Related supplement
Implantable Cardioverter Defibrillator, INOGEN (Models D010, D011, D012, D013, D140, D141, D142, D143); DYNAGEN (Models
P960040/S510 · Related supplement
D010 INOGEN MINI ICD VR, D011 INOGEN MINI ICD VR, D012 INOGEN MINI ICD DR, D013 INOGEN MINI ICD DR, D020 DYNAGEN MI
P960040/S511 · Related supplement
D010 INOGEN MINI ICD VR,D011 INOGEN MINI ICD VR,D012 INOGEN MINI ICD DR,D013 INOGEN MINI ICD DR,D020 DYNAGEN MINI I
P960040/S505 · Related supplement
NG3 Implantable Cardioverter Defibrillators (ICDs): DYNAGEN Models: D020, D021, D022, D023, D150, D151, D152, D153; INOG
P960040/S512 · Related supplement
VENTAK AV AICD VENTAK PRIZM DR/VR, VITALITY, COFIENT, AND TELIGEN AUTOMATIC IMPLANTABLE CARDIOVETER DEFIBRILLATOR SYSTEM
P960040/S507 · Related supplement
Implantable Cardioverter Defibrillators (ICD) RESONATE: D420, D421, D432, D433, D520, D521, D532, D533; MOMENTUM: D120,
P960040/S514 · Related supplement
INOGEN, DYNAGEN, MOMENTUM, VIGILANT EL, PERCIVA MINI, RESONATE EL, PERCIVA HF, RESONATE HF
P960040/S513 · Related supplement
TELIGEN, ENERGEN, PUNCTUA, INCEPTA, ORIGEN, INOGEN, DYNAGEN, AUTOGEN, RESONATE, MOMENTUM, VIGILANT, PERCIVA
P960040/S516 · Related supplement
ICD INOGEN VR DF4 (D010); ICD INOGEN VR DF1/IS1 (D011); ICD INOGEN DR DF4/IS1 (D012); ICD INOGEN DR DF1/IS1 (D013);
P960040/S515 · Related supplement
Tachy Pulse Generators
Timeline entries are records held by MedtechLedger for P960040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Boston Scientific | PMA supplement | Sep 22, 2025 | FDA | |
| Boston Scientific | PMA supplement | Oct 22, 2025 | FDA | |
| Boston Scientific | PMA supplement | Oct 22, 2025 | FDA | |
| Boston Scientific | PMA supplement | Jan 8, 2026 | FDA | |
| Boston Scientific | PMA supplement | Apr 1, 2026 | FDA | |
| Boston Scientific | PMA supplement | Apr 21, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jun 3, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jul 1, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jul 23, 2026 | FDA | |
Tachy Pulse GeneratorsP960040/S515 | Boston Scientific | PMA supplement | Aug 25, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P960040/S509
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





